Introduction
Apoptosis or programmed cell death plays a fundamental role in the control of cell proliferation and the maintenance of cell homeostasis (Harrington et al., 1994; Jacobson et al., 1997; Kerr et al., 1972; Wyllie et al., 1980) . Polypeptide growth factors are known to suppress cell death after interaction with the respective receptors and subsequent activation of speci®c transduction pathways (Segal and Greenberg, 1996; Stewart and Rotwein, 1996) . The product of the growth arrest speci®c gene gas6 (Gas6) (Man®oletti et al., 1993 ) is a growth factor identi®ed as the ligand for Axl/Ufo tyrosine kinase receptors (RTK) (referred thereafter as Axl) (Janssen et al., 1991; O'Bryan et al., 1991; Varnum et al., 1995) . Axl is a RTK de®ning a subfamily of RTK with Rse/Sky, c-Mer/Nyk and Rek (Biscardi et al., 1996; Graham et al., 1994; Ling and Kung, 1995; Mark et al., 1994) . More recent studies have shown that Gas6 can similarly bind and activate Rse/Sky and Mer RTK, although with lower anity (Chen et al., 1997; Mark et al., 1996; Nagata et al., 1996; Ohashi et al., 1995) . Gas6 was shown to act as a growth factor for ®broblasts, Schwann cells, chondrocytes, thyroid and vascular smooth muscle cells (Goruppi et al., 1996; Li et al., 1996; Loeser et al., 1997; Nakano et al., 1995; Tanaka et al., 1998) . In most of the cellular systems Gas6 has been reported to protect cells from apoptosis independently of its growth stimulating activity (Avanzi et al., 1997; Bellosta et al., 1997; Goruppi et al., 1996; , therefore suggesting that induction of proliferation and prevention of apoptosis could involve elements in distinct (parallel) pathways.
Ras proteins are members of the superfamily of small GTPases regulated by guanosine nucleotides that play a key role in cell proliferation and survival. Consistently activation of p21Ras is promoted by growth factors and cytokines (Downward, 1988a; Kyriakis and Avruch, 1996) . The conformational change adopted by GTP bound Ras allows the interaction with other signalling molecules such as Raf1 kinase and phosphatidylinositol 3-OH kinase (PI3K). Interaction with Raf1 leads to activation of downstream protein kinase MAP kinase/ ERK kinase (MEK) and extracellular signal-regulated kinase (ERK) while PI3K activation leads to production of phosphorylated phosphatidyl-inositides with regulatory functions on the kinases PDK and AKT/PKB (Downward, 1998a; Marshall, 1996; McCormick, 1993) .
PI3K is a heterodimeric enzyme directly activated by several RTKs and has been recently shown to be involved in the survival response of a number of dierent cell types (Carpenter and Cantley, 1996) . A direct mediator of PI3K-induced survival is the serine threonine kinase AKT/PKB (Bellacosa et al., 1991; Franke et al., 1997; Yao and Cooper, 1995) shown to block cell death by phosphorylating and inactivating Bad, a pro-apoptotic member of the Bcl-2 family (Datta et al., 1997) . Therefore a survival pathway has been de®ned starting from growth factor receptor activation leading to sequential activation of PI3K and AKT which in turn block Bad-mediated cell death by phosphorylating Bad at a speci®c residue.
Proin¯ammatory cytokines, cellular stress and growth factors have been reported to preferentially activate the Ras-related GTP-binding proteins of the Rho family, namely Rac and Cdc42Hs (Kyriakis and Avruch, 1996) . Such a signalling pathway leads to the stimulation of the stress activated protein kinases phosphorylating c-Jun (SAPK or JNK) and p38 Map kinases, which result in the subsequent regulation of speci®c transcriptions factors (Coso et al., 1995; Minden and Karin, 1997; Robinson and Cobb, 1997 ). An integral member coupling and regulating Rac and Cdc42 signalling to JNK/p38 is the p21-regulated Ser/Thr kinase Pak (Kyriakis and Avruch, 1996; Minden and Karin, 1997) . In fact Rac and Cdc42 in their active form bind and activate Pak; dominant negative Pak suppresses interleukin 1, UV and growth factor induced JNK and p38 activation (Zhang et al., 1995) . Growth factors such as EGF have been shown to activate the JNK pathway through PI3K (Logan et al., 1997) . Overexpression of PI3K catalytic subunit (p110) can lead to Rac activation (Klippel et al., 1996; Minden et al., 1995; Minden and Karin, 1997) and its expression in COS cells was shown to induce activation of JNK (Rei et al., 1996) . Taken together these data suggest that the PI3K activated pathway could be similarly involved in coupling Rac signalling to stress activated kinases.
In addition to the central role of the caspase protease family and the Bcl-2 family of apoptosis regulators, recent reports have indicated that JNK and the related p38 MAPK may be involved in the control of apoptosis (Kyriakis and Avruch, 1996) . In fact activation of JNK and p38, in the absence of ERK activity, was shown to induce cell death in neuronal cells (Estus et al., 1994; Xia et al., 1995) and both have been reported to mediate cell death induced by UV irradiation, cisplatin, anysomycin and heat shock in ®broblasts (Zanke et al., 1996) . However in other systems, JNK activation appears to play a protective role with respect to cell death (Sakata et al., 1995) . In addition, activation of both JNK and p38 were recently shown to be uncoupled from detachment-induced cell death (anoikis) of MDCK cells . Therefore the exact role of JNK/p38 MAPK in the events regulating cell death has still to be clari®ed.
We have recently characterized part of the signal transduction pathway by which Gas6 protects serum starved NIH3T3 cells from cell death induced by complete serum withdrawal (Goruppi et al., 1997) . The aim of this work was to further elucidate the Gas6-dependent signal transduction pathway required to protect NIH3T3 cells from cell death after complete serum removal. We found that Gas6 requires the activity of the small GTPases of the Rho family and the kinase activity of the downstream Pak but was independent of Ras. In addition, the presence of an active AKT/PKB was necessary for Gas6-mediated survival protection. Finally, we report that Gas6 activates ERK, JNK/SAPK and p38 mitogen-activated protein kinases. While ERK activation was not required for protection from cell death, constitutive p38 MAPK downregulation as observed at later times after Gas6 treatment might be involved in its survival activity.
Results

Ras blocking antibodies ablate Gas6-induced mitogenesis
Most tyrosine kinase receptors (RTK) were shown to activate the Ras-dependent pathway through Grb2 and/or Shc adapters (McCormick, 1993; Van der Geer et al., 1994) . Consistent with this, Axl cytoplasmic domain was shown to bind Grb2 protein (Braunger et al., 1997; Fridell et al., 1995) and Gas6 addition to serum starved cells induced a signi®cant activation of Shc (Goruppi et al., 1996) . To have further insights on the role of Ras in Gas6 signalling, we analysed the eects of microinjection of two well characterized anti Ras monoclonal antibodies on Gas6-induced mitogenesis. Serum starved NIH3T3 cells (48 h in 0.5% FCS) were microinjected in the cytoplasm either with the anti v-H-ras monoclonal antibody that is able to inhibit Ras activity (Y13-259) or with the non blocking anti v-H-ras monoclonal (Y13-238) as control. After 2 h, synchronous S phase re-entry was induced by addition of Gas6 (400 ng/ml ®nal concentration) and monitored by bromodeoxyUridine (BrdU) incorporation. Cells were ®xed at 24 h and processed for double immunouorescence with anti rat and anti BrdU antibodies. The representative ®eld of Figure 1a and the histograms in Figure 1b indicate that microinjection of Ras blocking antibodies completely abolished Gas6-induced cell cycle re-entry, whereas injection of the control anti Ras antibody had no signi®cant eect. In separate experiments Ras blocking antibodies similarly inhibited epidermal growth factor (EGF) and platelet derived growth factor (PDGF) induced S phase (not shown), therefore con®rming the strict requirement of an active Ras for the Gas6-stimulated mitogenic signal.
Ras blocking antibodies do not ablate Gas6-induced survival
Gas6 was reported to eciently prevent apoptosis induced by complete serum withdrawal from serum starved NIH3T3 cells (Bellosta et al., 1997; Goruppi et al., 1996) . Such survival activity was shown to be uncoupled from mitogenesis since Gas6 was not able to induce BrdU incorporation in the complete absence of serum (Goruppi et al., 1996) . We therefore investigated whether Gas6-induced survival was also dependent on Ras. Quiescent NIH3T3 cells were microinjected with the Ras blocking and Ras non-blocking antibodies and after 2 h the starvation medium was changed to serum free medium to induce cell death for 22 h. The total number of injected cells was counted at the time of microinjection and after the immuno¯uorescent staining with anti-Ras antibodies. Survival was expressed as the percentage of cells stained for anti-Ras antibodies that were recovered after 24 h from microinjection. Interestingly, microinjection of the Ras blocking antibody did not signi®cantly interfere with Gas6 induced survival (Figure 2a) , and the recovery of cells in the presence of Gas6 was similar to the non blocking antibody.
The involvement of Ras on Gas6 survival activity was further analysed by using a dominant negative Ras (rasN17). Serum starved NIH3T3 cells were co-injected with the expression vector encoding the dominant negative Ras and the human trasferrin receptor (TrR) as marker. After 6 h the starvation medium was changed to serum-free medium to induce cell death. In separate experiments either Gas6 (400 ng/ml) or PDGFbb (100 ng/ml) were added to the medium as survival factors. PDGF was selected as survival factor given its similarity with Gas6 in the requirement for mitogenic signalling (Goruppi et al., 1997) . As control TrR was co-injected under similar conditions with a ras carrying a mutation in the eector region (rasA38) that is known to abolish completely its biological functions (Marshall, 1996; Rodriguez-Viciana et al., 1997) . Survival was expressed as the percentage of TrR positive cells that were recovered after the immunouorescent staining versus total injected cells. Figure 2b shows that expression of a dominant negative Ras abolished PDGF survival activity while not significantly interfering with Gas6-induced recovery of cells. Conversely, when RasA38 cDNA was similarly coinjected with TrR, or TrR was injected alone, PDGF was able to recover the overexpressing cells as eciently as Gas6. These results thus con®rm our previous ®ndings that Gas6 is able to recover cell death as induced by complete serum deprivation and show Figure 1 Ras blocking antibodies ablate Gas6 mitogenic eect. Growth arrested NIH3T3 cells were microinjected in the cytoplasm with anti Ras blocking or non-blocking antibodies (3 mg/ml) and after 2 h cell cycle re-entry was induced with 400 ng/ml (+Gas6). BromodeoxyUridine (BrdU) (50 mM) was added together with Gas6 to monitor S phase entry. After the indicated times, cells were ®xed and double immuno¯uorescences were performed with goat anti rat polyclonal antibodies FITCconjugated (anti Ras) and anti BrdU monoclonal antibodies (anti BrdU). Second antibody for BrdU was a goat anti IgG2a conjugated to RITC. Figure 1 . After 2 h, cell death was induced by complete serum withdrawal from the medium, and the cells were incubated for further 22 h. Recombinant Gas6 (400 ng/ml) was either added or not to the cells as survival factor. After the indicated time, the cells were analysed by immuno¯uorescence as described in Figure 1 . The mean of four experiments and the standard deviation of the mean are reported here. (b) Ectopic expression of dominant negative Ras does not interfere with Gas6-dependent survival activity. Serum starved NIH3T3 cells were co-injected in to the nucleus with pEXV rasN17 (20 ng/ml) or rasA38 (20 ng/ml) and human trasferrin receptor (TrR) (50 ng/ ml) as microinjection marker. A parallel experiment was carried out injecting TrR alone as control. After 6 h cell death was induced by changing the medium to serum-free. In separate experiments either Gas6 (400 ng/ml) or PDGF (100 ng/ml) were added as survival factors. After the indicated time, the cells were ®xed, analysed and scored for TrR overexpression by using anti TrR monoclonal antibody OKT9. Secondary antibody was a goat anti mouse IgG1 FITC conjugated (Southern). The mean of four independent experiments and the standard deviations are shown Gas6 and apoptosis S Goruppi et al that Ras is dispensable for Gas6-dependent survival activity on serum starved NIH3T3 cells.
Involvement of Rac and Rho in Gas6-dependent survival
Gas6 antiapoptotic activity was previously shown to require the phosphatidylinositol 3 OH kinase (PI3K) pathway (Goruppi et al., 1997) and several lines of evidence have implicated the involvement of PI3K in the regulation of Rho GTPases Van Aelst and D'Souza-Schorey, 1997) . To determine the role of downstream PI3K eectors in Gas6-dependent survival signalling, we analysed the eect of overexpressing dominant negative Rac (racN17) or Rho (rhoN19). TrR was co-injected in quiescent NIH3T3 cells with either racN17 or rhoN19 and after 6 h medium was changed to serum-free. Four hundred ng of recombinant Gas6 per ml were added to the serum-medium as survival factor with respect to serum-free alone. After 20 h from microinjection cells were ®xed and analysed for TrR overexpression. Survival was evaluated as described in Figure 2 . Figure 3a indicates that expression of either Rac or Rho dominant negative constructs completely abolished Gas6-induced survival of serum starved cells while, as similarly shown in Figure 2a , microinjection of the cDNA encoding for TrR alone had no signi®cant eect on the Gas6-induced recovery of cells. Neither racN17 nor rhoN19 interfered with FCS-induced survival, excluding nonspeci®c or toxic, eects due to overexpression of the constructs. In addition, microinjection of the Rho-related, Cdc42Hs dominant negative mutant, under the same experimental conditions similarly blocked Gas6-dependent survival activity (not shown). To validate the speci®c requirements of a Rac-dependent pathway in Gas6-induced survival, we similarly analysed a Pak dominant negative mutant. Pak has been reported to bind Rac/ Cdc42 in a GTP-dependent manner thus mediating their speci®c responses (Symons, 1996; Van Aelst and D'Souza-Schorey, 1997) . A Pak cDNA containing a point mutation rendering the enzyme catalytically inactive (Pak K-), thereby behaving as a dominant negative in vivo (Zhang et al., 1995) , was co-injected with TrR into the nuclei of quiescent NIH3T3 cells. After 3 h cell death was induced by changing the medium to serum-free medium, with either Gas6 (400 ng/ml) or serum (10%), being separately added as survival factors. Figure 3b indicate that ectopic expression of the dominant negative Pak abolished Gas6-stimulated survival, while not interfering with FCS-induced survival. These results strongly implicate both Rac, Rho and the downstream kinase Pak in Gas6 regulated survival.
Activation of AKT is sucient for Gas6 survival function
AKT/PKB is a well characterized downstream target of PI3K with serine/threonine kinase activity which is catalytically inactive in serum starved ®broblasts (Burgering and Coer, 1995; Franke et al., 1995) . Its enzymatic activity is rapidly induced by addition of growth factors and was shown to be involved in the protection from apoptosis in a number of cellular systems (Franke et al., 1997; Marte and Downward, 1997) . In order to examine its involvement in Gas6 antiapoptotic signalling, NIH3T3 cells were serum starved and stimulated for 0, 10 or 20 min with 400 ng/ml recombinant Gas6 after the total withdrawal of serum. At the indicated times cells were washed with cold PBS and endogenous AKT proteins were immunoprecipitated with anti-AKT polyclonal antibodies. In parallel experiments, cells were incubated in serum-free DMEM for 10 min without Gas6 and the AKT kinase activity was similarly analysed. Figure 4a shows the results of a typical experiment where AKT kinase activity was induced rapidly after Gas6 exposure Serum starved NIH3T3 cells were microinjected into the nucleus with plasmids encoding either racN17 (20 ng/ml) or rhoN19 (20 ng/ml) together with TrR (50 ng/ ml). At the time indicated, as in the experimental scheme, cell death was induced by changing the medium to serum-free DMEM and in separate experiments either Gas6 (400 ng/ml) or serum (FCS) were added as survival factors. Parallel experiments were performed microinjecting TrR alone as control. The cells were scored for TrR overexpression as described in Figure 2 . The results of ®ve independent experiments together with the standard deviations are shown. (b) Gas6-induced survival requires Pak kinase activity. Growth arrested NIH3T3 cells were injected with expression vector encoding dominant negative Pak (Pak K-) (20 ng/ml) together with TrR (50 ng/ml). After 3 h cell death was induced as indicated above and cells were ®xed after further 17 h (see experimental scheme in the lower panel). In separate experiments either Gas6 (400 ng/ml) or serum (FCS) were added as survival factors. Immuno¯uorescence was carried out as reported in Figure 2 . The mean of four independent microinjection experiments together with the standard deviation of the mean are shown
Gas6 and apoptosis S Goruppi et al but was not detectable in unstimulated, serum deprived cells. Activation was transient reaching a peak 10 ± 15 min after Gas6 addition to the cells (not shown). The requirement of AKT for Gas6-dependent signalling was further investigated by microinjectionmediated ectopic expression of a kinase inactive AKT mutant (AKT K-) that behaves as a dominant negative (Franke et al., 1995) together with a TrR cDNA as a microinjection marker. As a control the cDNA encoding the wild type AKT was similarly expressed with the human TrR. Starvation medium was changed to serum-free 3 h after microinjection and the cells incubated for further 17 h in presence or absence of Gas6 or serum. After this time cells were ®xed and immuno¯uorescent staining for the co-injection marker, human TrR, was used for calculating cell recovery. Figure 4c shows that AKT K-overexpression abolished Gas6-induced survival while having no signi®cant eect upon serum-stimulated survival. When wild type AKT was used instead of the kinase defective AKT, no decrease in Gas6 or serum-induced cell recovery were observed. These results show that Gas6 survival activity absolutely requires the presence of an active AKT kinase and con®rm our previous ®ndings indicating that Gas6 stimulates a PI3K activated pathway in serum starved NIH3T3.
AKT was reported to block apoptosis induced by growth factor withdrawal, loss of cell adhesion and DNA damage (Franke et al., 1997; Marte and Downward, 1997) . These antiapoptotic eects were recently linked to the phosphorylation of the Bcl-2 family member Bad (Datta et al., 1997) . We therefore investigated whether Gas6 addition in quiescent cells in serum free medium was able to induce endogenous Bad phosphorylation. For such experiments we took advantage of the previous ®ndings that, after Bad phosphorylation, a slowly migrating Bad form can be detected on SDS ± PAGE (Datta et al., 1997; Wang et al., 1996; Zha et al., 1996) . Serum starved NIH3T3 cells were left untreated or changed to serum free in the presence or absence of Gas6 (400 ng/ml). Equal amounts of total cellular lysates, assessed by Coomassie staining or separate gels, were analysed by Western blot with anti Bad antibodies. In agreement with the rapid kinetics of AKT kinase activation observed upon Gas6 addition, Gas6-induced Bad phosphorylation occurs within minutes after survival factor addition (Figure 4b ). These ®ndings are consistent with previous reports using IL-3, PDGF and NGF as survival factors (Datta et al., 1997; Zha et al., 1996) and similarly suggest that Gas6-dependent survival may act by interfering with Bad induced cell death.
Map kinase cascade is not required for Gas6-dependent survival
Among the signal transduction pathways activated by growth factors, the best characterized is the Ras activated kinase cascade that culminates in the activation of ERK members of the MAPK family (Minden and Karin, 1997; Robinson and Cobb, 1997) . We previously showed that Gas6 addition to serum starved NIH3T3 cells induces the activation of MAPK (Goruppi et al., 1996) . We thus considered the dependence of such Ras activated signalling in Gas6-mediated antiapoptotic activity by using the speci®c Mek inhibitor PD98059 (Alessi et al., 1995) . In order to assay the lowest PD98059 concentration inhibiting Gas6 activation of MAPK in serum-free conditions, serum starved NIH3T3 cells were treated for 1 h with increasing amounts of drug (0, 1, 10, 20, 50 mM) before changing the medium to serum-free and addition of Gas6 for 10 min. We found that the lowest concentra- Figure 4 AKT is required for Gas6-mediated survival. (a) In vivo activation of AKT kinase after Gas6 addition. Kinase assay was performed using serum starved NIH3T3 cells stimulated for 10 min with 400 ng/ml of Gas6 after complete removal of serum. Equal amounts of total cell lysates were immunoprecipitated with anti AKT polyclonal antibodies (Santa Cruz Biotechnologies) and the kinase assays were performed as described in the Materials and methods section. As a control a separate Western blot analysis was carried out on the same total lysates with anti AKT antibodies as previously reported (Graham et al., 1994) . (b) Ectopic expression of akt K-abrogates Gas6-induced survival. Serum starved NIH3T3 cells were microinjected into the nucleus with pCMV akt K-(20 ng/ml) encoding the dominant negative, kinase dead AKT, together with TrR (50 ng/ml) as a marker. After 3 h the medium was changed to serum-free to induce cell death (7) and either 400 ng/ml Gas6 (Gas6) or serum (FCS) were added at the same time as survival factors. As a control, NIH3T3 cells were similarly microinjected with wild type pCMV akt cDNA (wt) (ng/ml). After the time indicated, cells were scored for TrR overexpression as described in Figure 2 . The mean of four independent experiments and the standard deviations are shown. (c) Gas6 induces Bad phosphorylation. Western blot analysis with anti Bad antibodies (Santa Cruz Biotechologies) on cellular lysates from serum starved NIH3T3 cells stimulated + or not 7 for 10 min with Gas6 (400 ng/ml) after changing the medium to serum-free. Phosphorylation of Bad results in the appearance of a slower-migrating form (asterisk) on SDS ± PAGE (Datta et al., 1997) Gas6 and apoptosis S Goruppi et al tion of PD98059 inhibiting the Gas6-induced MAPK activation was 20 mM (Figure 5a ), as similarly reported for EGF and NGF (Alessi et al., 1995) . Therefore serum starved NIH3T3 cells were treated with 20 mM PD98059 before changing the medium to serum-free, with or without addition of Gas6. Parallel treatment with 1 mM wortmannin (Ui et al., 1995) was used since it was previously shown that wortmannin eciently blocks MAPK activation by Gas6 (Goruppi et al., 1997) . Cells were lysed and the MAPK were immunoprecipitated from equal amounts of lysates with anti ERK2 antibodies. In vitro kinase assays were performed using [g-32 P]ATP and the Myelin Basic Protein (MBP) as exogenous substrate for the ERKs. Figure 5c shows that PD98059 eectively inhibited the in vivo activation of MAPK kinase activity in response to Gas6 similarly to wortmannin. Such eect was speci®c for the MAPK pathway since no inhibition of S6K, an element involved in Gas6 antiapoptotic signalling (Goruppi et al., 1997) , was found under similar conditions (Figure 5c ).
The ability of PD98059 to interfere with Gas6-induced survival was then investigated in vivo. Serum starved NIH3T3 cells were treated with 20 mM PD98059 for 1 h before changing the medium to serum-free in order to induce cell death. In separate experiments PD98059 (20 mM) was added with serum-free medium, either containing or not Gas6 (400 ng/ml) or serum (10% FCS) as survival factors. Control survival activity of Gas6 in the absence of drug was monitored in parallel experiments. After 20 h, cell viability was evaluated by measuring the uptake of 3-[4,5-dimethyltiazol-2-yl]-2,5-diphenyltetrazoliumbromide (MTT) for 4 h at 378C (Buttke et al., 1993) . The results of four independent experiments are shown in the Figure 5b . PD98059 addition to serum starved NIH3T3 cells did not interfere signi®cantly with either Gas6 or serum-dependent protective eect (Figure 5c) . We have previously shown that the Gas6-mediated survival eect can be evidenced by analysing the cleavage of a speci®c endogenous substrate of apoptotic proteases (Brancolini et al., 1995; Goruppi et al., 1996) . Serum starved cells were pretreated with PD98059 and stimulated with Gas6 or FCS as reported above and subjected to Gas2 analysis. After 20 h both adherent and non-adherent apoptotic cells were combined for Western blot analysis with anti Gas2 antibodies. Consistent with the results obtained using MTT dye, addition of 20 mM PD98059 to the cell Increasing concentrations of PD98059 (0, 1, 10, 20 and 50 mM) in DMSO were added to the medium of serum starved NIH3T3 cells before changing it to serum free and stimulation with Gas6 (400 ng/ml ®nal concentration) for 10 min. Equal amounts of total cellular lysate were analysed by Western blot using anti ERK2 polyclonal antibodies as previously reported (Goruppi et al., 1996) . (b) PD98059 blocks MAPK activation by Gas6. Serum starved NIH3T3 cells were treated with 20 mM PD98059 or 1 mM wortmannin as control (for 1 h and 30 min respectively) before stimulation with 400 ng/ml of recombinant Gas6 for 10 min. Equal amounts of total proteins were immunoprecipitated using anti ERK2 polyclonal antibodies (Santa Cruz Biotechologies) and kinase assays were carried out using myelin basic protein (MBP) as exogenous substrate (as Materials and methods section). The autoradiography is representative of three separate experiments. An aliquot of the total cell lysates used for the kinase assay were analysed by Western blot for S6K activation as previously described (Goruppi et al., 1997) . (c) Gas6-induced survival activity is insensitive to PD98059. Serum starved NIH3T3 cells were pre-treated as above with 20 mM PD98059 before changing the medium to serum free DMEM (7). In separate experiments 400 ng/ml of Gas6 (Gas6) or serum (FCS) were added to the medium as survival factors with or without the drug. As control, one petri dish was left untreated. Cell viability was evaluated after 20 h by adding MTT 0.5 mg/ml for further 4 h. Percentage of survival was expressed relative to 100% as the survival of untreated, quiescent cells. The mean of four independent experiments and the standard deviation of the mean are reported here. Western blot analysis with anti Gas2 antibody on cellular lysates derived from serum starved NIH3T3 cells incubated for 24 h in serum-free DMEM (7) or supplemented with Gas6 (+) (400 ng/ml). Separate petri dishes were treated with PD98059 (20 mM) and similarly stimulated with Gas6 or serum (FCS). For Western blot analysis, both adherent and non adherent cells were combined; Gas2 cleavage becomes evident as a higher-mobility form in 15% SDS ± PAGE (Goruppi et al., 1996) medium did not interfere signi®cantly with Gas6 or serum-induced survival, as evidenced by the absence of the apoptotic faster migrating form of Gas2 (Figure 5b, lower panel) . Taken together, these data strongly suggest that MAPK activity is not required for antiapoptotic signalling by Gas6.
Gas6-dependent downstream survival signalling in NIH3T3 cells
Several growth factors have been shown to activate the c-Jun terminal kinase (JNK), through PI3K (Logan et al., 1997; Minden and Karin, 1997; Minden et al., 1995) . To determine whether JNK is activated by Gas6-dependent survival signalling, JNK activity was measured at various times after induction of cell death and Gas6 addition. Starvation medium of a 10 cm petri dish of quiescent NIH3T3 cells was changed to serum-free DMEM for 10 and 20 min and in separate experiments 400 ng of recombinant Gas6 per ml were added or not to the petri dish. After the indicated times, cells were washed with cold PBS and the JNK kinase analysed. Endogenous JNK kinases were isolated from stimulated and unstimulated cells by immunoprecipitation with anti JNK antibodies and in vitro kinase reaction was performed using recombinant c-Jun as substrate. Notably, Gas6 addition strongly induced JNK activity within minutes from stimulation whereas changing medium to serum-free had no detectable eect on JNK activity (Figure 6a ). However, as reported for other strong JNK activators such as EGF and UV (Derijard et al., 1994) , the activation was transient and no signi®cant JNK activity was detectable after 20 h (data not shown). Cell lysates used for JNK immunoprecipitation and kinase assays were checked for equal amounts of total proteins by determining Axl receptor expression in parallel Western blots (Figure 6a ). To investigate the role of PI3K in Gas6-stimulated JNK activation, wortmannin was used to abrogate PI3K activity. We previously reported that Gas6 signalling is blocked by addition of wortmannin and have demonstrated the central role of PI3K for Gas6-induced survival and mitogenesis (Goruppi et al., 1997) . Thus serum starved cells were treated for 1 h with 1 mM wortmannin or 20 mM PD98059, a non related inhibitor, before stimulation with Gas6. In Figure  6b we show that wortmannin addition completely abolished Gas6 stimulated JNK activation, while treatment with PD98059 did not signi®cantly aect JNK activation (Figure 6b ). When a dierent PI3K inhibitor, LY 294002, was used at a ®nal concentration of 10 mM in these same experimental conditions, abrogation of Gas6 signalling to JNK was similarly observed (not shown). These results suggest that in serum starved NIH3T3 ®broblasts Gas6 survival signalling may progress from PI3K via Rac to the JNK kinase cascade.
Role of the p38 MAPK pathway in Gas6-induced survival
Growth factors have been shown to inhibit cellular apoptosis by interfering with the p38 MAPK pathway.
In fact p38 MAPK activity is very eciently repressed by insulin after serum withdrawal from postmitotic neurons and PC12 cells (Kummer et al., 1997) . We therefore analysed the involvement of p38 MAPK in Gas6-dependent survival of NIH3T3 cells. Quiescent NIH3T3 ®broblasts in a 10 cm petri dish were either stimulated or not with Gas6 in serum-free medium for 0, 10, 20 or 30 min. In parallel experiments cells were similarly stimulated with 100 ng/ml of EGF, 100 ng/ml of insulin or UV irradiated (40 J/m 2 ) as a positive control. In addition two petri dishes were pre-treated either with wortmannin or PD98059 before Gas6 addition for 30 min. The lysates were assessed for equal amounts of protein by staining separate gels with Coomassie and analysed by Western blot using commercial phospho-speci®c antibodies to p38 MAPK. Figure 7a shows that Gas6 addition in serum-free conditions induced a transient activation of p38 MAPK (Figure 7a ). Such p38 MAPK activation returned to basal levels within 20 min after Gas6 Figure 6 Gas6 addition activates JNK. (a) Gas6 induces activation of c-Jun terminal kinase (JNK). Serum starved NIH3T3 cells were stimulated (+) for 0, 10 and 20 min with 400 ng of recombinant Gas6 per ml after complete serum removal from medium (sf). Cells in separate petri dishes were left without addition of Gas6 (7) as a control. Equal amounts of total proteins were immunoprecipitated using anti JNK polyclonal antibodies (Santa Cruz Biotechnologies) and the kinase assays were performed using c-Jun as exogenous substrate (as in Materials and methods section). Equal amounts of proteins were assessed on a separate Coomassie-stained gel and by Western blotting with anti Axl polyclonal antibodies (lower panel). (b) Gas6-induced JNK activation is mediated by PI3K. Growth arrested NIH3T3 cells were treated (+) or not (7) treated with either 20 mM PD98059 or 1 mM wortmannin (Wort) before stimulation for 20 min with Gas6 (40 ng/ml) in serum-free DMEM. After this time cell were lysed and kinase assays were carried out as in a. Equal amounts of proteins were assessed on a separate Coomassie-stained gel and by Western blotting with anti Axl polyclonal antibodies (lower panel) (Figure 7a ). The recent availability of speci®c inhibitors acting within the p38 MAPK subtype suggested their use to further investigate the involvement of such a pathway for Gas6-dependent survival. Serum starved NIH3T3 cells were treated with 25 mM of SB203580 for 1 h before changing the medium to serum-free DMEM in order to induce cell death. The drug was then added together with serum-free medium in the absence or presence of either Gas6 (400 ng/ml) or FCS (10%) to block cell death. Survival activity of the factors was evaluated in the absence of SB203580 in parallel experiments. After 20 h cell viability was monitored by measuring the uptake of MTT for 4 h at 378C. Consistent with previous reports (Kummer et al., 1997) , abrogation of p38 MAPK activation significantly enhanced cell survival in serum free conditions (Figure 7b ). Moreover we have found that p38 MAPK inhibitor SB203580 can eciently decrease also cell death induced by wortmannin addition under the same Figure 7 Role of p38 MAPK pathway in Gas6-dependent survival. (a) Gas6 addition induces with MAPK phosphorylation. Serum starved NIH3T3 cells were stimulated for 0, 10, 20 and 30 min with Gas6 (400 ng/ml) or left untreated in serum-free medium. Separate petri dishes cells were treated with either PD98059 (20 mM) or wortmannin (1 mM) before stimulation with Gas6 for 30 min. As control cells were stimulated either with EGF (100 ng/ml) or insulin (100 ng/ml) or UV irradiated (40 J/m 2 ) for 10, 30 and 30 min respectively. Equal amounts of total cellular lysates were analysed by Western blot using anti phospho-speci®c p38 MAPK antibodies (New England Biolabs). The histograms in the lower panel depicts the per cent dierence in p38 MAPK activity where serum starved NIH3T3 cells (48 h 0.5% FCS) were given a arbitrary value of 100%. As control a separate Western blot was decorated with anti p38 MAPK antibodies (Santa Cruz Biotechnologies) and is shown in the lower panel. (b) Gas6-induced survival activity is insensitive to SB203580. Serum starved NIH3T3 cells were pre-treated as above with 25 mM SB203580 before changing the medium to serum free DMEM (7). In separate experiments 400 ng/ml of Gas6 (Gas6) or serum (FCS) were added to the medium as survival factors. As control one petri dish was left untreated. Cell viability was evaluated using MTT dye and expressed as described in Figure 5 . The mean of four independent experiments and the standard deviation of the mean are reported here. (c) Gas6 blocks cell death induced by growth factor removal by interfering with p38 activity. Western blot analysis with anti phosphospeci®c anti p38 antibody on cellular lysates derived from serum starved NIH3T3 cells incubated for 20 h in serum-free DMEM (7) or serum-free supplemented with Gas6 (+) (400 ng/ml). Separate petri dish was UV irradiated (40 J/m 2 ) as positive control. The histograms in the lower panel indicate the per cent dierence in p38 MAPK activity and were calculated as in a. A separate Western blot was carried out using anti p38 MAPK antibodies to verify the amounts of total proteins loaded on each lane and is shown in the lower panel experimental conditions (not shown). Gas6 addition markedly increased cell recovery and the survival was further enhanced in the presence of SB203580. These data suggest involvement of p38 MAPK in the biological system used and a possible interference of Gas6 in such a pathway.
To better understand the relationship between p38 MAPK activation and Gas6-dependent survival signalling, p38 MAPK phosphorylation levels were determined at the time of MTT labelling as described above. Serum starved NIH3T3 cells were treated with Gas6 or UV irradiated to induce p38 phosphorylation as described for Figure 7a . Cellular lysates were prepared after 20 h and equal amounts of total proteins were analysed by Western blot with anti p38 phosphospeci®c antibodies. In serum starved NIH3T3 cells left untreated (0.5% FCS starvation medium) for 20 additional hours, p38 steady-state activation level remained low. After exchange of starvation serum with serum free medium, p38 MAPK activity was signi®cantly enhanced; in the presence of Gas6 however p38 MAPK activity was markedly downregulated (Figure 7c ). The higher rate of cell death induced by UV and serum-free conditions, as shown previously, correlated with sustained level of p38 MAPK phosphorylation. On the contrary, enhanced survival induced by Gas6 and insulin, as positive control, correlated with decreased p38 MAPK phosphorylation. Therefore these ®ndings suggest that Gas6-dependent survival response may act, after an initial and transient activation, by decreasing p38 MAPK activation.
Discussion
Gas6 is an emerging growth factor for epithelial and mesenchimal cells acting through the members of the Axl/Ufo tyrosine kinase receptor family. In addition to a weak mitogenic signal, the most prominent Gas6 feature is its ability to protect the cells from apoptosis induced by growth factor withdrawal (Goruppi et al., 1996; Nakano et al., 1996) , TNFa (Bellosta et al., 1997) and several other genotoxic stress (SG unpublished results). Since Gas6 expression is enhanced at growth arrest (Man®oletti et al., 1993) , it is likely that its survival-enhancing activity should be most relevant for quiescent cells, possibly indicating that signals departing from Axl act by interfering with speci®c elements involved in the apoptotic process. Here we have analysed the Gas6-activated signalling activities linked to its function as an inhibitor of cell death. The biological system used for our analysis consisted of serum starved NIH3T3 ®broblasts induced to die by complete growth factor removal from medium. Under these conditions Gas6 lacks any mitogenic activity, thus allowing the speci®c analysis of its survival pathway uncoupled from its mitogenic stimulation (Bellosta et al., 1997; Goruppi et al., 1996) .
An extensive literature exists implicating Ras both in induction and in the protection of apoptosis, the most notable dierence in its eects being presently explained by the dierent cell type or the apoptotic stimuli used (Downward, 1998a) . We have found that blocking Ras activity with speci®c antibodies abolished Gas6-induced mitogenesis but did not impair Gas6 mediated survival. On the contrary within the same experimental conditions PDGF-mediated survival activity yet required Ras, thus indicating a clear dierence between Gas6 and PDGF-survival inducing pathways. Both have the requirement of (Roche et al., 1994 (Roche et al., , 1995 PI3K activity to induce cell survival (Datta et al., 1997; Goruppi et al., 1997) however several reports clearly identi®ed Ras as an upstream eector required for PDGF-dependent PI3K activation (Rodriguez-Viciana et al., 1994; Datta et al., 1997) , while it is likely that Gas6-dependent PI3K activation does not require Ras in this biological system. In fact both wortmannin or p85 dominant negative eciently block Gas6 survival activities, together with its mitogenic eects (Goruppi et al., 1997) and Ras was indeed shown to be exclusively required for Gas6-dependent mitogenesis (this manuscript). Accordingly Hu et al. (1995) reported that, at least in some systems, Ras might behave as a downstream PI3K eector. Interestingly an overall reduction of cell survival was observed when RasN17, but not the Ras blocking antibody, was microinjected. This dierence might be explained by considering that a Ras blocking antibody should interfere speci®cally with the endogenous Ras, while a dominant negative Ras might also interfere with other potential Ras downstream elements, such as the AKT/PKB pathway, thus modifying the threshold for cell survival. Consistently, overexpression of à totally inactive A38 ras' (Khwaja and had no signi®cant eects within the same experimental conditions. Several lines of evidence have implicated the involvement of PI3K upstream of Rac and Rho in PDGF, EGF and Insulin induced cytoskeletal rearrangements in quiescent ®broblasts (Ridley, 1996) . Moreover additional reports have demonstrated physical or functional interaction between PI3 kinase and Rac, Rho or Cdc42Hs (Machesky and Hall, 1996; Tolias et al., 1995) . A strict requirement for the Rho family of GTPases in Gas6-mediated survival, as analysed with dominant negative constructs, supported the evidence for a speci®c Gas6-survival pathway departing from PI3K. This was further con®rmed by the complete abrogation of Gas6-induced survival through overexpression of a dominant negative Pak, a known downstream Rac/Cdc42Hs molecular target (Zhang et al., 1995) . Since RhoA neither activate any known MAPK cascade pathway in mammalian cells nor interact with Pak (Minden and Karin, 1997; Ridley, 1996) , we can hypothesize that the block of Gas6 cell survival activity by N17RhoA expression could be mediated through a dierent, Gas6-dependent, signalling pathway possibly involving the Rho-interacting kinase PKN or the phosphoinositide 5-kinase (PI5K) (Symons, 1996) .
Lipid products generated by PI3K activation lead to activation of the serine/threonine kinase AKT (Carpenter and Cantley, 1996) . AKT has been shown to block, or delay, cell death as induced by several apoptotic stimuli such as growth factor depletion, matrix detachment and c-myc activation (Franke et al., 1997; Marte and Downward, 1997; Kaumann-Zeh et al., 1997) . We have previously shown the requirement of PI3K for Gas6/Axl signalling (Goruppi et al., 1997) . Here we have found that activation of AKT kinase activity was signi®cantly induced by addition of the Gas6 and apoptosis S Goruppi et al survival factor Gas6 to serum starved cells. Accordingly ectopic expression of a dominant negative mutant AKT K-abolished Gas6-induced survival thus suggesting that AKT might mediate Gas6-induced protection from cell death by serum deprivation. Following this pathway Bad, a pro-apoptotic Bcl-2 related protein, has been shown as a substrate of AKT in cytokine and growth factor induced survival, its phosphorylation blocking pro-apoptotic activity in cultured neurons (Datta et al., 1997) . Here we show that a similar pathway seems to be activated by Gas6 in serum starved NIH3T3 cells. Accordingly Gas6-induced Bad phosphorylation should create a binding site for the ubiquitously expressed family of proteins 14-3-3, thus delivering Bcl-2 and Bcl-X L antiapoptotic activities (Del Peso et al., 1997; Zha et al., 1996) . However since Bad is expressed in a limited range of tissues and cell lines (Downward, 1998b) it is unlikely that this is the only mechanism by which a survival factor, such as Gas6, can prevent cell death. It is possible that Gas6-activated AKT kinase can additionally act on other unrelated components of the cell signalling pathway such as GSK3 and PFK kinase.
Recent ®ndings indicate an important role for ERKs in the protection of dierentiated PC12 cells from growth factor withdrawal (Xia et al., 1995) and ceramide-induced apoptosis (Cuvillier et al., 1996) . We have previously reported that Gas6 induces a transient activation of ERK (Goruppi et al., 1996) : we therefore analysed here the role of ERK in Gas6 survival signalling. Treatment of NIH3T3 cells with the speci®c Mek inhibitor PD98059 eciently blocked ERK activation by Gas6 but had no detectable eect on the Gas6 inhibition of cell death. In agreement with conclusions showing that ERK activity is not required for protection for UV irradiation by Insulin (Kulik et al., 1997) our ®ndings suggest that ERK activation might be dispensable for Gas6-mediated protection of cell death.
ERK and JNK/SAPK are proposed to have opposite roles in apoptosis of B cells: JNK/SAPK protecting and ERKs facilitating cell death (Sakata et al., 1995) . In other well de®ned systems JNK/SAPK may promote rather than protect against apoptosis (Xia et al., 1995; Zanke et al., 1996) . To investigate the role of JNK in Gas6 protection from cell death we ®rst analysed whether Gas6 addition to serum starved cells could in¯uence Jun kinase activation. We could demonstrate that Gas6 addition to the medium induced a signi®cant activation of the endogenous JNK activity. Given the central role for PI3K in Gas6 signalling as previously reported (Goruppi et al., 1997) we could show that such Gas6-dependent JNK activation was blocked by addition of the speci®c PI3K inhibitors wortmannin and LY294002 (not shown) but not by the Mek inhibitor PD98059. Moreover, as reported for EGF and TPA, Gas6-dependent induction of JNK activity was transient and no activity could be detected at later times (20 h) either in presence or absence of Gas6 (not shown). These results suggest that Gas6-activated pathway to JNK share similarities to EGF in the investigated biological system: EGF activates JNK in NIH3T3 cells and such activation was shown to be mediated by PI3K (Derijard et al., 1994; Logan et al., 1997) . However EGF does not protect serum starved NIH3T3 cells from cell death while Gas6 does it eciently. Therefore the eective contribution of JNK activation to Gas6-induced survival have to be further investigated by using speci®c drugs or dominant negative constructs blocking such pathway.
The activation of p38 MAPK is known to be induced by stress and in¯ammatory cytokines and recent evidence have suggested that certain growth factors might activate p38 MAPK as well. In fact FGF, NGF, GM-CSF, IL3 and EGF were shown to activate such a pathway (Kyriakis and Avruch, 1996; Minden and Karin, 1997) . We have analysed whether Gas6 was able to similarly induce p38 MAPK activation in NIH3T3 cells and we have found that Gas6 addition to serum starved cells was able to transiently increase p38 MAPK activity, albeit at signi®cantly lower levels than observed after EGF addition or UV irradiation. As suggested for other growth factors (Minden and Karin, 1997) Gas6-dependent transient p38 MAPK activation might be a general mechanism by which growth factors elicit cellular responses.
Most interestingly, enhanced p38 MAPK activity at later times was recently reported to correlate with cell death by apoptosis as induced after trophic factor withdrawal (Kulik et al., 1997; Kummer et al., 1997) . Moreover, as reported for PC12 and Rat1 cells, use of speci®c p38 MAPK inhibitor (Kummer et al., 1997) signi®cantly decreased cell death induced by serum withdrawal. We used the p38 MAPK inhibitor SB203580 in our cellular system and found that it eciently enhanced survival after growth factor withdrawal. After 20 h in the complete absence of serum, the steady-state level of p38 MAPK activity was signi®cantly elevated: addition of Gas6, enhancing survival at later times, signi®cantly decreased p38 MAPK steady state activity. As suggested for the eects of NGF on dierentiated PC12 cells and insulin on postmitotic neurons (Kummer et al., 1997) , we similarly suggest that Gas6 survival activity on serum deprived NIH3T3 cells might be mediated by inhibition of p38 MAPK apoptotic pathway. The existence of such a pathway is consistent with our ®nding that SB203580 can eciently decrease also cell death as induced by wortmannin addition to serum starved cells (not shown). The ability of Gas6 to interfere with p38 MAPK activity may thus contribute to explain the reported protection of NIH3T3 cells from TNFaactivated apoptotic program (Bellosta et al., 1997) . Interestingly, while no additive eects on cell survival were reported for Insulin in combination with a p38 MAPK inhibitor (Kummer et al., 1997) , when SB203580 and Gas6 were simultaneously added to the cells we could observe a slight and signi®cant cumulative eect suggesting the activation of additional survival pathways by Gas6. It is therefore plausible that Gas6 might stimulate dierent pathways supporting survival: integration of such multiple signalling pathways being the critical factor for determining cell survival. Additional experiments will be necessary to more speci®cally characterize the role of p38 MAPK downregulation at later time for Gas6-dependent survival.
In conclusion, Gas6-dependent signalling activates transiently ERK, JNK and p38 MAPK in quiescent NIH3T3 cells. With respect to their involvement in cell death by serum withdrawal, we have found that ERK activation was clearly dispensable for Gas6-dependent survival activity. At later times after induction of cell death we have detected a sustained activation for p38 MAPK but not for JNK. Interestingly, Gas6 was able to signi®cantly suppress such later p38 MAPK activation.
As shown by Bellosta and co-workers, Gas6 is unable to inhibit cell death in ®broblasts derived from Ark (Axl) knock-out mice (Bellosta et al., 1997) . Such cells express Rse/Tyro3, a member of the family with similar binding anity for Gas6 (Mark et al., 1996) , possibly suggesting that Rse/Tyro3 activation is not able to protect cells from cell death and that full Gas6 survival eect requires Axl RTK. It is interesting to note that even though the Axl cytoplasmic domain contains several tyrosines, with the potential binding sites for adapters, its signalling was shown to be mediated mainly by a multi-substrate docking site (Braunger et al., 1997) with a consensus binding site for PI3K Goruppi et al., 1997) . In the present report, we have identi®ed targets downstream of Gas6-activated PI3K that are required for its antiapoptotic signalling on serum starved NIH3T3 cells. We provide evidence that Gas6 interferes with cell death induced by growth factor depletion by inactivating apoptosis-related protein Bad, and downregulating the activity of apoptosis-associated p38 MAPK. Even though other members of Axl receptor family may have dierent functions in vivo, the signalling departing from Axl receptors which we have here described, may contribute to the control of tissue homeostasis by protecting quiescent cells from premature death under conditions of growth factor deprivation.
Materials and methods
Plasmids
pCMV6 plasmids containing HA-AKT K+ and dominant negative HA-AKT K-(K179M) cDNA were kindly provided by A Bellacosa. cDNA encoding pEXV H-ras(N17) was kindly provided by C Marshall. pEXV rac(N17) and rhoA(N19) were provided by A Hall. pEXV ras(A38) was a gift from S Volinia. Dominant negative pCMV5 Pak(K299R) cDNA was provided by G Bokoch. TrR cDNA was subcloned in pGDSV7 eucaryotic expression vector as previously described (Goruppi et al., 1997) .
Cell culture
NIH3T3 were grown routinely in Dulbecco's modi®ed Eagle medium (DMEM) supplemented with 10% foetal calf serum (FCS), penicillin (100 U/ml), and streptomycin (100 mg/ml). For growth arrest by serum starvation NIH3T3 cells were seeded at 1610 4 cells per cm 2 and after 24 h from plating in 10% FCS, medium was replaced with DMEM containing 0.5% FCS for 48 h. After this time incubation for 1 h with 50 mM BromodeoxyUridine (BrdU) (Fluka) resulted in less than 5% of BrdU positive nuclei. Wortmannin, sodium uoride, okadaic acid, b-glycerophosphate and sodium orthovanadate were from Sigma. Mek inhibitor PD98059 was purchased from New England BioLabs. p38 MAPK inhibitor SB203580 was from NC (Calbiochem Novabiochem).
Basic ®broblast growth factor (bFGF) was kindly supplied by Dr C Grassi-Farmitalia, Milano. Epidermal growth factor (EGF) was kindly provided by A Ullrich. Recombinant Gas6 and recombinant platelet derived growth factor (PDGFbb) were supplied by Amgen Inc.
Western blots
Analysis of MAPK, Bad and S6K activation was performed as described (Datta et al., 1997; Goruppi et al., 1997 ) (all antibodies were from SantaCruz laboratories). Loading of equal amount of total proteins was assessed by Coomassie staining of separate gels. After 10% SDS ± PAGE and transfer to polyvinyldi¯uoridene membrane (Millipore), Western blot analysis was carried out by using anti MAPK, anti Bad or anti S6K rabbit polyclonal antibodies (1 : 500 in milk) and visualized with a goat anti rabbit peroxidase conjugated second antibody (Southern) and ECL (Amersham, UK). Analysis of p38 MAPK activation was performed using phosphospeci®c anti p38 MAPK (New England Biolabs, Inc) diluted 1 : 1000 in blocking solution (20 mM Tris pH7.5, 100 mM NaCl, 0.01% Tween-20, 3% bovine albumine from serum-Sigma). As loading control a separate Western blot was performed using a rabbit polyclonal antibody anti p38 MAPK (Santa Cruz Biotechnologies). Total cellular lysates were prepared from stimulated and unstimulated cells by adding SDS ± PAGE loading buer to the petri dish, separated and transferred to nitrocellulose membrane. Western was revealed as above described.
When wortmannin (1 mM), SB203580 (20 mM) or PD98059 (20 mM) were used, they were added to the starvation medium (for 30, 60 and 60 min respectively) prior to changing medium with serum free. Fresh drugs were added at the same initial concentration again to the serum-free medium before growth factor stimulation.
Immunocomplex kinase assays
In order to assay for c-Akt protein kinase activation, NIH3T3 cells serum starved in a 10 cm petri dish were stimulated for 0, 10 and 20 min with 400 ng/ml of Gas6. Cells were lysed in 1 ml of ice cold lysis buer (150 mM NaCl, 50 mM Tris pH 7.5, 1% Triton X-100, 5 mM EDTA, 2 mM sodium orthovanadate, 2 mM NaF, 1 mM PMSF, CLAP 10 mg/ml (aprotinin, leupeptin, antipain and pepstatin, all from Boehringer Mannheim)). Lysates were transferred to Eppendorf tubes, vortexed, incubated 10 min and then centrifuged for 15 min at 10 000 g in Eppendorf centrifuge to remove insoluble material. The supernatants were precleared by incubation for 30 min with protein A sepharose (Pharmacia) (10% v/v ®nal concentration) and then incubated on ice with 1 mg of anti AKT polyclonal antibodies (Santa Cruz Biotechnologies) for 60 min. After this time, 10 ml of Ultralink Protein A (Pierce) were added to the lysates and incubated for 45 min at 48C on a rotating platform. Immunoprecipitates were washed three times in lysis buer and twice in kinase assay buer (20 mM HEPES pH 7.4, 20 mM b-Glycerophospate, 10 mM MgCl 2 , 10 mM Na 3 VO 4 ). Reactions were performed in 20 ml of kinase buer containing 5 mCi of [g-32 P]ATP, (370 MBq/mmol, Amersham, UK) and 2 mg of histone H2B (Boehringer Mannheim) as exogenous substrate for 15 ± 20 min at 308C. Reactions were terminated by adding 5 ml of 56 SDS ± PAGE loading buer, resolved on 10% SDS ± PAGE. The dried gel was exposed o/n at room temperature with intensifying screens (Dupont Cronex).
For MAPK and JNK kinase assays, serum starved NIH3T3 cells from a 10 cm petri dish were lysed in 800 ml of ice cold RIPA buer (150 mM NaCl, 1% NP40, 0.4% DOC, 0.1% SDS, 50 mM Tris pH 8) additionated with 20 mM b-glycerophospate, 10 mM Na 3 VO 4 , 20 mM NaF, 1 mM Okadaic acid, 1 mM PMSF, 10 mg/ml CLAP. After centrifugation at 14K for 10 min in an eppendorf centrifuge, whole cell extracts were incubated for 60 min on ice with 2 mg of anti ERK2 or anti JNK1 polyclonal antibodies (Santa Cruz Biotechnologies). The antibodies were recovered by adding 15 ml of Ultralink Protein A (Pierce) for 45 min at 48C. Immune complexes were washed three times in lysis buer and then twice in kinase buer (20 mM HEPES pH7.5, 20 mM b-glycerophospate, 10 mM MgCl 2 , 10 mM DTT, 10 mM Na 3 VO 4 ) Reactions were carried out for 30 min at 308C in 30 ml of kinase buer containing 10 mCi of [g-32 P] ATP, (370 MBq/mmol, Amersham, UK), 1 mM ATP and 2 mg of MBP or His tagged c-Jun as substrates. In all assays, phosphorylated proteins were resolved by 15% SDS ± PAGE and visualized by autoradiography. Myelin basic protein (MBP) was purchased from Sigma while c-jun 66His cDNA, kindly provided by C Santoro, was anity puri®ed in non denaturing conditions on NTA column (Quiagen) as suggested by the manufacturer.
Cell death assays
Serum starved NIH3T3 cells in a 6 cm petri dish were incubated either with 20 mM PD98059 or 25 mM SB203580 for 1 h or left untreated. After this time the cells were washed twice with warm PBS and the medium changed to serum-free to induce cell death. When drugs were used, 20 mM PD98059 or 25 mM SB203580 were freshly added together with the serum-free medium. The cells were left either in absence of growth factors or Gas6 (400 ng/ml) or 10% serum were added as survival factors.
After 20 h 0.5 mg/ml MTT (3-[4,5-dimethyltiazol-2-yl]-2,5-diphenyltetrazoliumbromide) was added to the cells to monitor viability after further incubation for 4 h at 378C. The labelling was stopped by adding 10% SDS-0.01% HCl at room temperature. Absorbance was measured at a wavelength of 595 nm. All the experiments were carried out in duplicate.
Analysis of Gas2 cleavage after cell death induction in serum starved NIH3T3 cells was performed with anti Gas2 speci®c antibodies essentially as previously described (Goruppi et al., 1996) . Serum starved NIH3T3 cells treated as above in a 10 cm petri dish incubated for 24 h in DMEM serum free containing or not either 400 ng/ml of Gas6 or serum (10% FCS) as control. After this time, both adherent and non adherent cells were combined and SDS lysates were separated by 15% SDS ± PAGE and analysed by Western blot. Equal loading of proteins was assessed by separate gels stained with Coomassie blue.
Microinjection
All experiments were performed using an Automated Injection System AIS (Zeiss, Oberkochen, Gemany). Rat anti Ras antibodies Y13-259 and Y13-238 (3 mg/ml) (Oncogene Science) previously dialyzed against 25 mM KCl were microinjected into the cytoplasm of serum starved NIH3T3 cells. Two hours later 400 ng/ml of Gas6 were added to the starvation medium together with 50 mM BromodeoxyUridine (BrdU) (Fluka) to monitor cell cycle re-entry. Immuno¯uorescence staining was performed 22 h later using FITC conjugated anti Rat antibodies (Southern Biotechnologies) while BrdU was stained using a IgG2a monoclonal antibodies (Amersham, UK) as previously described (Goruppi et al., 1996) . For survival analysis 200 quiescent cells were similarly microinjected; after 2 h cells were washed once and serum free medium was added in presence or not of Gas6 (400 ng/ml) or PDGFbb (100 ng/ml) as survival factors. Twenty hours later, cells were ®xed and anti Ras immuno¯uorescence was performed as above.
Analysis of Gas6 survival activity using plasmid DNA was performed by co-injecting 200 quiescent NIH3T3 cells with (20 ng/ml) of pEXV19Nrho, pEXV17Nrac, pEXVN17ras, pEXVA38ras, pCMV6Akt, pCMV6Akt K-or pCMV5Pak K-together with (50 ng/ml) of human trasferrin receptor cDNA (pGDSV7-TrR) as marker. After the indicated times (see ®gure legends for speci®cations), cells were washed once and serum-free medium containing Gas6 (400 ng/ml) or dierent growth factors was added. Twenty hours later, cells were ®xed and immuno¯uorescence was performed with IgG1 monoclonal antibody OKT9 anti TRr. The second antibody was a FITC labelled goat anti IGG1 (Southern). All experiments were analysed using an inverted Zeiss microscope with the following ®lters: rhodamine BP 546, FT 580, LP 590; uoresceine BP 450-490, FT 510, LP520, Hoechst G 365, FT 395, LP 420.
